Results 241 to 250 of about 290,195 (301)

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw   +5 more
wiley   +1 more source

The Biodistribution of <sup>99m</sup>Tc Labelled Equine Peripheral Blood Mesenchymal Stem Cells in Healthy and Chronic Gingivostomatitis Cats. [PDF]

open access: yesVet Sci
Beerts C   +8 more
europepmc   +1 more source

Extensive sucrose cycling through the fructan pool of a C3 grass across a 200 to 800 μmol mol-1 atmospheric CO2 gradient. [PDF]

open access: yesPlant Physiol
Zhu J   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

To Label or Not to Label

JAMA: The Journal of the American Medical Association, 1967
ABSTRACT To the Editor:— A pharmaceutical firm advertises its identification code for its drug products, with the suggestion that this code could be lifesaving. Other devices could be equally lifesaving. A recent note in The Journal states that pharmacists need not label prescriptions unless requested by the physician to do so.
openaire   +4 more sources

Home - About - Disclaimer - Privacy